webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Boc-D-Orn(N3)-OH CHA

  CAS No.: 1858224-18-6   Cat No.: BADC-01785   Purity: >98% 4.5  

Boc-D-Orn(N3)-OH (CHA) is a versatile ADC linker intermediate designed for efficient bioorthogonal click chemistry in antibody-drug conjugates. It enables precise payload attachment with high stability, optimizing drug delivery in targeted cancer therapies. Key keywords: ADC linker, azide functional linker, bioconjugation, cleavable linker.

Boc-D-Orn(N3)-OH CHA

Structure of 1858224-18-6

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C16H31N5O4
Molecular Weight
357.45
Shipping
Store at 2-8 °C

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
Boc-D-Orn(N3).CHA; (R)-Boc-2-amino-5-azido-pentanoic acid CHA salt; Boc-D-azidonorvaline CHA salt; Boc-D-Nva(5-N3).CHA; D-Norvaline, 5-azido-N-[(1,1-dimethylethoxy)carbonyl]-, compd. with cyclohexanamine (1:1); Boc-D-Orn(N3) CHA salt; N-alpha-t-Butyloxycarbonyl-delta-azido-D-ornithine cyclohexylamine; (R)-2-t-Butyloxycarbonylamino-5-azidopentanoic acid cyclohexylamine; (R)-5-Azido-2-((tert-butoxycarbonyl)amino)pentanoic acid cyclohexylamine
IUPAC Name
(2R)-5-azido-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoic acid;cyclohexanamine
Canonical SMILES
CC(C)(C)OC(=O)N[C@H](CCCN=[N+]=[N-])C(=O)O.C1CCC(CC1)N
InChI
InChI=1S/C10H18N4O4.C6H13N/c1-10(2,3)18-9(17)13-7(8(15)16)5-4-6-12-14-11;7-6-4-2-1-3-5-6/h7H,4-6H2,1-3H3,(H,13,17)(H,15,16);6H,1-5,7H2/t7-;/m1./s1
InChIKey
OTASSZHMIDGDAW-OGFXRTJISA-N
Storage
Store at 2-8 °C

Boc-D-Orn(N3)-OH (CHA), a versatile compound widely employed in chemical biology and medicinal chemistry, boasts diverse applications across multiple domains. Here are four key applications of Boc-D-Orn(N3)-OH (CHA), presented with high perplexity and burstiness:

Chemical Synthesis: Acting as a cornerstone in peptide synthesis, Boc-D-Orn(N3)-OH (CHA) serves as a protected derivative of amino acids. The Boc protective group imparts stability during synthesis, while the azide group facilitates subsequent bio-orthogonal reactions. This compound stands as a pivotal building block for crafting intricate peptide structures and functionalized biomolecules, showcasing its profound significance in the realm of chemical synthesis applications.

Click Chemistry: Within the domain of click chemistry, the azide group within Boc-D-Orn(N3)-OH (CHA) plays a pivotal and indispensable role in reactions like the azide-alkyne cycloaddition. These reactions exhibit unparalleled efficiency and compatibility with a wide array of biological conditions, enabling the formation of biomolecular conjugates. This application is essential for various purposes such as labeling, imaging, and the development of cutting-edge bioconjugates for both research and therapeutic pursuits.

Drug Development: In the dynamic arena of drug development, Boc-D-Orn(N3)-OH (CHA) contributes significantly to the creation of prodrugs and innovative drug delivery systems. Tailoring the azide group allows for the attachment of therapeutic agents or targeting moieties, enhancing drug efficacy and selectivity. This strategic approach empowers controlled release and targeted therapy, offering substantial benefits in treating diverse diseases through the utilization of Boc-D-Orn(N3)-OH (CHA).

Proteomics: Within the intricate landscape of proteomics research, Boc-D-Orn(N3)-OH (CHA) finds invaluable utility in site-specific protein labeling. The azide moiety interacts seamlessly with alkynes to affix fluorescent probes or other tags, facilitating the exploration of protein interactions and functions. This application plays a pivotal role in unraveling protein dynamics and illuminating protein networks, underscoring the critical importance of Boc-D-Orn(N3)-OH (CHA) in advancing the field of proteomics studies.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: SIA Crosslinker | Tr-PEG3-OH | Mal-PEG3-C1-NHS ester | Aminoxyacetamide-PEG3-azide | N-Boc-MeVal | m-PEG12-OH | mPEG10-amine | Hemiasterlin | mPEG5-acetic acid | BCN-SS-NHS | Boc-L-4-trans-hydroxyproline methyl ester
Send Inquiry
Verification code
Inquiry Basket